IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 63 filers reported holding IDERA PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $552,000 | -40.4% | 367,938 | +1.7% | 0.00% | 0.0% |
Q3 2016 | $926,000 | +80.9% | 361,750 | +8.2% | 0.00% | 0.0% |
Q2 2016 | $512,000 | -17.0% | 334,389 | +7.3% | 0.00% | 0.0% |
Q1 2016 | $617,000 | -35.0% | 311,598 | +1.5% | 0.00% | 0.0% |
Q4 2015 | $949,000 | -7.0% | 307,084 | +0.9% | 0.00% | 0.0% |
Q3 2015 | $1,020,000 | -10.1% | 304,334 | -0.5% | 0.00% | 0.0% |
Q2 2015 | $1,134,000 | +21.8% | 305,782 | +21.8% | 0.00% | 0.0% |
Q1 2015 | $931,000 | +18.8% | 250,998 | +41.2% | 0.00% | 0.0% |
Q4 2014 | $784,000 | +90.3% | 177,788 | -1.1% | 0.00% | 0.0% |
Q3 2014 | $412,000 | -18.6% | 179,745 | +3.0% | 0.00% | 0.0% |
Q2 2014 | $506,000 | – | 174,431 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 4,525,000 | $7,874,000 | 1.40% |
DAFNA Capital Management LLC | 200,000 | $348,000 | 0.38% |
HealthCor Management, L.P. | 3,270,000 | $5,690,000 | 0.30% |
Baker Brothers Advisors | 5,865,000 | $10,205,000 | 0.14% |
Spark Investment Management LLC | 152,500 | $262,000 | 0.06% |
NATIXIS | 3,148,916 | $5,479,000 | 0.06% |
GUARDIAN LIFE INSURANCE CO OF AMERICA | 371,759 | $647,000 | 0.05% |
LEAVELL INVESTMENT MANAGEMENT, INC. | 81,271 | $141,000 | 0.02% |
TFS CAPITAL LLC | 118,232 | $206,000 | 0.01% |
First Eagle Investment Management, LLC | 1,434,296 | $2,496,000 | 0.01% |